Abstract
Dihydropyridine calcium channel blockers may possess antioxidant properties, and might improve micro and macrovascular structure and function. Combination treatment with an ACE inhibitor may have additional advantages, compared with a thiazide diuretic. The aim of the present study is to investigate the effects of a short-term treatment with lercanidipine, and to compare two combination treatments: lercanidipine + enalapril vs. lercanidipine + hydrochlorothiazide on structural alterations in retinal arterioles, on skin capillary density and on large artery distensibility. Thirty essential hypertension patients are included in the study, and treated for 4 weeks with lercanidipine 20 mg per day orally. Then, they were treated for 6 months with lercanidipine + enalapril (n = 15) or lercanidipine + hydrochlorothiazide (n = 15) combinations. Investigations were performed on basal condition, after appropriate wash out of previous treatments, after 4 weeks of lercanidipine monotherapy treatment, and at the end of the combination treatment. Non-invasive measurements of wall-to-lumen ratio (WLR) and other morphological parameters of retinal arterioles were performed using either scanning laser Doppler flowmetry or adaptive optics. Capillary density was evaluated by capillaroscopy, while pulse wave velocity was measured, and central blood pressures were assessed by pressure waveform analysis. A significant improvement of WLR and other indices of retinal artery structure is observed with both technical approaches after treatment with lercanidipine alone, with a further improvement after treatment with lercanidipine + enalapril, while after treatment with lercanidipine + hydrochlorothiazide, the improvement is partially blunted. Central systolic and diastolic blood pressures are similarly reduced by both therapeutic strategies. Capillary density is increased only after treatment with lercanidipine + enalapril. In conclusion, lercanidipine both in monotherapy and in combination with enalapril but not with hydrochlorothiazide is able to improve microvascular structure; on the other hand, a decrease in central blood pressure is observed with both therapeutic combinations.
Similar content being viewed by others
References
Mulvany MJ, Aalkjaer C (1990) Structure and function of small arteries. Physiol Rev 70:921–971
Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti Rosei E (1996) Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 28:785–790
Schiffrin EL (2004) Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17:1192–1200
Struijker Boudier HAJ (1999) Microcirculation in hypertension. Eur Heart J 1(Suppl. L):L32–L37
Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HAJ (2001) Microcirculation in hypertension. A new target for treatment? Circulation 104:735–740
Tsioufis C, Dimitriadis K, Katsiki N, Tousoulis D (2015) Microcirculation in hypertension: an update on clinical significance and therapy. Curr Vasc Pharmacol 13:413–417
Paiardi S, Rodella LF, De Ciuceis C, Porteri E, Boari GE, Rezzani R, Rizzardi N, Platto C, Tiberio GA, Giulini SM, Rizzoni D, Agabiti-Rosei E (2009) Immunohistochemical evaluation of microvascular rarefaction in hypertensive humans and in spontaneously hypertensive rats. Clin Hemorheol Microcirc 42:259–268
Safar ME, O’Rourke ME (2006) Handbook of hypertension, vol 23, Arterial Stiffness in Hypertension. Elsevier, Amsterdam, p 598
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H, European Network for Non-invasive Investigation of Large Arteries (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27:2588–2605
Muiesan ML, Salvetti M, Rizzoni D, Paini A, Agabiti-Rosei C, Aggiusti C, Bertacchini F, Stassaldi D, Gavazzi A, Porteri E, De Ciuceis C, Agabiti-Rosei E (2013) Pulsatile hemodynamics and microcirculation: evidence for a close relationship in hypertensive patients. Hypertension 61:130–136
Laurent S, Agabiti-Rosei E. The cross-talk between the macro- and the microcirculation. In: Nilsson P, Olsen MH & Laurent S Eds Early Vascular Aging (EVA): new directions in cardiovascular protection. Elsevier Inc, London, UK, pp 105–118
Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E (2003) Prognostic significance of small-artery structure in hypertension. Circulation 108:2230–2235
Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:1236–1241
Laurent S, Rizzoni D. Targeting central blood pressure through the micro-and macrocirculation cross-talk. In: Nilsson P, Olsen MH, Laurent S (eds) Early vascular aging (EVA): new directions in cardiovascular protection. Elsevier Inc, London, UK, pp 297–306
Agabiti-Rosei E, Heagerty AM, Rizzoni D (2009) Effects of antihypertensive treatment on small artery remodelling. J Hypertens 27:1107–1114
Rizzoni D, De Ciuceis C, Salvetti M, Paini A, Rossini C, Agabiti-Rosei C, Muiesan ML (2015) Interactions between macro- and micro-circulation: are they relevant? High Blood Press Cardiovasc Prev 22:119–128
Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O’Rourke M, CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee (2006) Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 113:1213–1225
Taddei S, Virdis A, Ghiadoni L, Magagna A, Favilla S, Pompella A, Salvetti A (2001) Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 37(3):943–948
Savoia C, Schiffrin EL (2007) Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 112:375–384
De Ciuceis C, Salvetti M, Rossini C, Muiesan ML, Paini A, Duse S, La Boria E, Semeraro F, Cancarini A, Agabiti Rosei C, Sarkar A, Ruggeri G, Caimi L, Ricotta D, Rizzoni D, Agabiti Rosei E (2014) Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. J Hypertens 32:565–574
Virdis A, Savoia C, Grassi G, Lembo G, Vecchione C, Seravalle G, Taddei S, Volpe M, Agabiti Rosei E, Rizzoni D (2014) Evaluation of microvascular structure in humans: a ‘state-of-the-art’ document of the Working Group on Macrovascular and Microvascular Alterations of the Italian Society of Arterial Hypertension. J Hypertens 32:2120–2129
Rizzoni D, Porteri E, Duse S, De Ciuceis C, Rosei CA, La Boria E, Semeraro F, Costagliola C, Sebastiani A, Danzi P, Tiberio GA, Giulini SM, Docchio F, Sansoni G, Sarkar A, Agabiti Rosei E (2012) Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry. J Hypertens 30:1169–1175
Bang LM, Chapman TM, Goa KL (2003) Lercanidipine: a review of its efficacy in the management of hypertension. Drugs 63:2449–2472
Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti G, Magagna A, Salvetti A (2003) Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension 41:950–955
De Ciuceis C, Rossini C, Tincani A, Airò P, Scarsi M, Agabiti-Rosei C, Ruggeri G, Caimi L, Ricotta D, Agabiti-Rosei E, Rizzoni D (2016) Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension. Blood Press 25:337–343
Borghi C, Cicero AF (2010) Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril. Clin Drug Investig 30:843–854
Tocci G, Palano F, Pagannone E, Chin D, Ferrucci A, Volpe M (2009) Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine. Expert Rev Cardiovasc Ther 7:115–123
Koch E, Rosenbaum D, Brolly A, Sahel JA, Chaumet-Riffaud P, Girerd X, Rossant F, Paques M (2014) Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes. J Hypertens 32:890–898
Rizzoni D, Docchio F (2016) Assessment of retinal arteriolar morphology by noninvasive methods: the philosopher’s stone? J Hypertens 34:1044–1046
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Task Force Members (2013) ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013(31):1281–1357
Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E (1992) Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 5:180–186
Salvetti M, Agabiti Rosei C, Paini A, Aggiusti C, Cancarini A, Duse S, Semeraro F, Rizzoni D, Agabiti Rosei E, Muiesan ML (2014) Relationship of wall-to-lumen ratio of retinal arterioles with clinic and 24-hour blood pressure. Hypertension 63:1110–1115
Harazny JM, Ritt M, Baleanu D, Ott C, Heckmann J, Schlaich MP, Michelson G, Schmieder RE (2007) Increased wall:lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event. Hypertension 50:623–829
Ritt M, Harazny JM, Ott C, Schlaich MP, Schneider MP, Michelson G, Schmieder RE (2008) Analysis of retinal arteriolar structure in never-treated patients with essential hypertension. J Hypertens 26:1427–1434
Rosenbaum D, Mattina A, Koch E, Rossant F, Gallo A, Kachenoura N, Paques M, Redheuil A, Girerd X (2016) Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics. J Hypertens 34:1115–1122
Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA (1999) Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 34(4 Pt 1):655–658
Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA (1999) Structural skin capillary rarefaction in essential hypertension. Hypertension 33:998–1001
De Ciuceis C, Rossini C, Porteri E, La Boria E, Corbellini C, Mittempergher F, Di Betta E, Sarkar A, Agabiti Rosei C, Casella C, Nascimbeni R, Rezzani R, Rodella LF, Borsani E, Enrico Agabiti Rosei E, Rizzoni D (2013) Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery. Blood Press 22:165–172
Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E (2004) Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 43:731–738
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W, American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology (2006) Recommendations for chamber quantification. Eur J Echocardiogr 7:79–108
De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260
Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS (2012) Mannheim carotid intima-media thickness and plaque consensus (2004–2006–2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 34:290–296
Muiesan ML, Salvetti M, Paini A, Monteduro C, Agabiti Rosei C, Aggiusti C, Belotti E, Bertacchini F, Galbassini G, Stassaldi D, Castellano M, Agabiti Rosei E (2010) Pulse wave velocity and cardiovascular risk stratification in a general population: the Vobarno study. J Hypertens 28:1935–1943
Heagerty AM (2007) Predicting hypertension complications from small artery structure. J Hypertens 25:939–940
Schiffrin EL, Deng LY (1996) Structure and function of resistance arteries of hypertensive patients treated with a beta blocker or a calcium channel antagonist. J Hypertens 14:1237–1244
Debbabi H, Uzan L, Mourad JJ, Safar M, Levy BI, Tibiriçà E (2006) Increased skin capillary density in treated essential hypertensive patients. Am J Hypertens 19:477–483
Debbabi H, Bonnin P, Levy BI (2010) Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients. Am J Hypertens 23:1136–1143
Zhou MS, Schulman IH, Jaimes EA, Raij L (2008) Thiazide diuretics, endothelial function, and vascular oxidative stress. J Hypertens 26:494–500
Neutel JM (1996) Metabolic manifestations of low-dose diuretics. Am J Med 101:71S–82S
Feig DI (2012) The role of uric acid in the pathogenesis of hypertension in the young. J Clin Hypertens (Greenwich) 14:346–352
De Ciuceis C, Rossini C, Airò P, Scarsi M, Tincani A, Tiberio GA, Piantoni S, Porteri E, Solaini L, Duse S, Semeraro F, Petroboni B, Mori L, Castellano M, Gavazzi A, Agabiti Rosei C, Agabiti Rosei E, Rizzoni D (2017) Relationship between different subpopulations of circulating CD4+ T-lymphocytes and microvascular structural alterations in humans. Am J Hypertens 30:51–60
De Ciuceis C, Agabiti-Rosei C, Rossini C, Airò P, Scarsi M, Tincani A, Tiberio GA, Piantoni S, Porteri E, Solaini L, Duse S, Semeraro F, Petroboni B, Mori L, Castellano M, Gavazzi A, Agabiti-Rosei E, Rizzoni D (2017) Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans. Blood Press 26:237–245
Bruno RM, Duranti E, Ippolito C, Segnani C, Bernardini N, Di Candio G, Chiarugi M, Taddei S, Virdis A (2017) Different impact of essential hypertension on structural and functional age-related vascular changes. Hypertension 69:71–78
Safar ME, Rizzoni D, Blacher J, Muiesan ML, Agabiti-Rosei E (2008) Macro and microvasculature in hypertension: therapeutic aspects. J Hum Hypertens 22:590–595
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
The protocol of the study was approved by the Ethics Committee of our institution (Medical School, University of Brescia). The procedures followed were in accordance with institutional guidelines.
Informed consent
Informed consent was obtained from each participant.
Rights and permissions
About this article
Cite this article
De Ciuceis, C., Salvetti, M., Paini, A. et al. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension. Intern Emerg Med 12, 963–974 (2017). https://doi.org/10.1007/s11739-017-1696-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-017-1696-7